Triple O Research Institute PA
West Palm Beach, Florida, 33401, United States
NCT Number: NCT02322827
This study is designed to see how HIV infected patients perform when taking a single fixed dose HIV medication compared to a regimen with multiple tablets. The study is also going to be looking at the differences in complications between the two groups.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
West Palm Beach, Florida, 33401, United States
This is a phase IV retrospective chart review of HIV infected patients in a private Infectious disease practice in West Palm Beach, FL. This chart review will assign patients into one of two groups based on their antiretroviral regimen: single tablet regimen (STR) versus multi tablet regimen (MTR). Up to 650 patient charts will be reviewed but only about 500 patients are needed for statistical analysis.
The primary objective is to look at the proportion of patients with an adherence rate greater than or equal to 95% in subjects prescribed STR versus a MTR.
Secondary Objectives:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Time frame: 2 years
composite
Time frame: 1year
Time frame: 2 years
Time frame: 2 years
Time frame: 1 year
Time frame: 1 year
Time frame: 2 years
Olayemi Osiyemi MD
Other
Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed a Single Tablet Regimen (STR) Versus Multi Tablet Regimen (MTR).
Acronym: HOST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04983030
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Los Angeles, California, United States
View Trial DetailsNCT05031819
Acquired Immunodeficiency Syndrome, Blood Pressure
Uyo, Akwa Ibom State, Nigeria
View Trial DetailsNCT04772469
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Siaya, Kenya
View Trial DetailsNCT02639754
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Sofia, Bulgaria
View Trial Details